Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety in Normal Volunteers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07554222
What this trial is testing

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

Who this might be right for
HealthyActive Non-segmental VitiligoSevere Alopecia Areata
Innovent Biologics (Suzhou) Co. Ltd. 160
Early research (Phase 1)WithdrawnNCT00005827
What this trial is testing

Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center
Early research (Phase 1)UnknownNCT06041165
What this trial is testing

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401

Who this might be right for
Hyperlipidemia
Shanghai Junshi Bioscience Co., Ltd. 44
Early research (Phase 1)Study completedNCT05765357
What this trial is testing

Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers

Who this might be right for
Metastatic Breast CancerMetastatic Gastric Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 89
Early research (Phase 1)Study completedNCT00814645
What this trial is testing

Dose-Finding, Safety, Pharmacodynamic Effect Study of Sodium Nitrite Inhalation Solution in Normal, Healthy Volunteers

Who this might be right for
Pulmonary Arterial Hypertension
Aires Pharmaceuticals, Inc. 25
Early research (Phase 1)Looking for participantsNCT07604324
What this trial is testing

A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Novartis Pharmaceuticals 63
Early research (Phase 1)Study completedNCT06082323
What this trial is testing

A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers

Who this might be right for
Healthy VolunteerHidradenitis SuppurativaAtopic Dermatitis
Leadingtac Pharmaceutical (Shaoxing) Co., Ltd. 150
Early research (Phase 1)Study completedNCT02717988
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of a Single Oral Dose of SKI-O-703 in Healthy Volunteers

Who this might be right for
Rheumatoid Arthritis
Oscotec Inc. 48
Early research (Phase 1)Ended earlyNCT01359579
What this trial is testing

The Pharmacokinetics and Safety of Varespladib in Subjects With Normal or Impaired Renal Function

Who this might be right for
Renal Impairment
Anthera Pharmaceuticals 28
Early research (Phase 1)Study completedNCT02646358
What this trial is testing

Study of the Effect of Renal Impairment on the Pharmacokinetics of Vepoloxamer

Who this might be right for
Pharmacokinetics of VepoloxamerHealthy VolunteersRenal Impaired
Mast Therapeutics, Inc. 27
Early research (Phase 1)Study completedNCT00547014
What this trial is testing

First Safety Study in Humans of a Single Dose of CPG 52364

Who this might be right for
Healthy Volunteers
Pfizer 61
Early research (Phase 1)UnknownNCT04853823
What this trial is testing

A Safety, Tolerability, and Dermal Reactogenicity Study of PDC-APB

Who this might be right for
Contact Dermatitis
Hapten Sciences, Inc. 32
Early research (Phase 1)Study completedNCT02548806
What this trial is testing

Phase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers

Who this might be right for
Healthy
Valerio Therapeutics 36
Early research (Phase 1)Study completedNCT06230588
What this trial is testing

A Clinical Trial of TQH3906 Capsules in Healthy Volunteers

Who this might be right for
Psoriasis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 96
Early research (Phase 1)UnknownNCT02205320
What this trial is testing

A Comparative, Crossover, Pharmacokinetic, Pharmacodynamic and Safety Study of Three Forms of PEG-G-CSF in Normal Healthy Volunteers

Who this might be right for
Pharmacokinetics
Dr. Reddy's Laboratories Limited 192
Early research (Phase 1)Study completedNCT01484548
What this trial is testing

Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers

Who this might be right for
Leishmaniasis
Access to Advanced Health Institute (AAHI) 36
Early research (Phase 1)Study completedNCT03647982
What this trial is testing

Anhidrotic Area and Safety of MEDITOXIN in Healthy Male Valunteers

Who this might be right for
Anhidrotic AreaHyperhidrosis
Medy-Tox 13
Not applicableStudy completedNCT05499247
What this trial is testing

A Proof-of-Concept, Safety and Efficacy Study of SkinQ Glow Bright Wonder Mask in Healthy Human Subjects

Who this might be right for
Healthy Human Volunteers With Visibly Tanned Skin
NovoBliss Research Pvt Ltd 38
Early research (Phase 1)Looking for participantsNCT07181369
What this trial is testing

GTX-B001 in Healthy Subjects and Patients With Chronic Inducible Urticaria

Who this might be right for
Healthy SubjectsCold UrticariaSymptomatic Dermographism+1 more
Granular Therapeutics Limited 72
Early research (Phase 1)Study completedNCT02130414
What this trial is testing

PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects

Who this might be right for
Healthy
Sigmoid Pharma 48
Next Page